APA

Jiang N., Lin J., Wang J., Zhang B., Li A., Chen Z., Guo S., Li B., Duan Y., Yan R., Yan H., Fu X., Zhou J., Yang H. & Cui Y. (2018). Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs. : Experimental and therapeutic medicine.

Chicago

Jiang Nan, Lin Jing-Jing, Wang Jun, Zhang Bei-Ning, Li Ao, Chen Zheng-Yang, Guo Song, Li Bin-Bin, Duan Yu-Zhong, Yan Ru-Yi, Yan Hong-Feng, Fu Xiao-Yan, Zhou Jin-Lian, Yang He-Ming and Cui Yan. 2018. Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs. : Experimental and therapeutic medicine.

Harvard

Jiang N., Lin J., Wang J., Zhang B., Li A., Chen Z., Guo S., Li B., Duan Y., Yan R., Yan H., Fu X., Zhou J., Yang H. and Cui Y. (2018). Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs. : Experimental and therapeutic medicine.

MLA

Jiang Nan, Lin Jing-Jing, Wang Jun, Zhang Bei-Ning, Li Ao, Chen Zheng-Yang, Guo Song, Li Bin-Bin, Duan Yu-Zhong, Yan Ru-Yi, Yan Hong-Feng, Fu Xiao-Yan, Zhou Jin-Lian, Yang He-Ming and Cui Yan. Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs. : Experimental and therapeutic medicine. 2018.